Spots Global Cancer Trial Database for negative
Every month we try and update this database with for negative cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer | NCT01596751 | Metastatic Brea... | PLX3397 Eribulin | 18 Years - | University of California, San Francisco | |
Evaluation of Half-Dose Molecular Breast Imaging With Wide Beam Reconstruction Processing | NCT01653964 | Breast Cancer | Molecular breas... | 40 Years - | Mayo Clinic | |
Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer | NCT01596751 | Metastatic Brea... | PLX3397 Eribulin | 18 Years - | University of California, San Francisco |